Susquehanna International Group
DGX icon

Susquehanna International Group’s Quest Diagnostics DGX Stock Holding History

Susquehanna International Group’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.63M Sell
18,519
-12,109
-40% -$2.35M ﹤0.01% 4865
2025
Q4 		$5.31M Buy
30,628
+13,696
+81% +$2.49M ﹤0.01% 3919
2025
Q3 		$3.23M Buy
16,932
+1,479
+10% +$262K ﹤0.01% 4839
2025
Q2 		$2.78M Sell
15,453
-21,279
-58% -$3.7M ﹤0.01% 5119
2025
Q1 		$6.22M Sell
36,732
-25,021
-41% -$4.11M ﹤0.01% 3244
2024
Q4 		$9.32M Buy
61,753
+37,131
+151% +$5.78M ﹤0.01% 2745
2024
Q3 		$3.82M Sell
24,622
-4,715
-16% -$704K ﹤0.01% 4090
2024
Q2 		$4.02M Buy
29,337
+2,939
+11% +$402K ﹤0.01% 3807
2024
Q1 		$3.51M Sell
26,398
-35,964
-58% -$4.67M ﹤0.01% 4214
2023
Q4 		$8.6M Buy
62,362
+6,964
+13% +$916K ﹤0.01% 2837
2023
Q3 		$6.75M Buy
55,398
+8,724
+19% +$1.16M ﹤0.01% 3079
2023
Q2 		$6.56M Sell
46,674
-16,062
-26% -$2.21M ﹤0.01% 3099
2023
Q1 		$8.88M Sell
62,736
-3,862
-6% -$553K ﹤0.01% 2617
2022
Q4 		$10.4M Buy
66,598
+63,342
+1,945% +$9.1M ﹤0.01% 2217
2022
Q3 		$399K Sell
3,256
-21,666
-87% -$2.85M ﹤0.01% 9061
2022
Q2 		$3.31M Sell
24,922
-30,250
-55% -$4.12M ﹤0.01% 3892
2022
Q1 		$7.55M Buy
55,172
+25,904
+89% +$3.61M ﹤0.01% 2952
2021
Q4 		$5.06M Sell
29,268
-41,144
-58% -$6.26M ﹤0.01% 3715
2021
Q3 		$10.2M Buy
70,412
+21,777
+45% +$3.19M ﹤0.01% 2831
2021
Q2 		$6.42M Buy
48,635
+29,584
+155% +$3.87M ﹤0.01% 3578
2021
Q1 		$2.44M Sell
19,051
-3,990
-17% -$492K ﹤0.01% 5427
2020
Q4 		$2.75M Sell
23,041
-33,511
-59% -$4.09M ﹤0.01% 4462
2020
Q3 		$6.47M Sell
56,552
-29,596
-34% -$3.5M ﹤0.01% 2740
2020
Q2 		$9.82M Buy
86,148
+8,224
+11% +$872K ﹤0.01% 2154
2020
Q1 		$6.26M Buy
77,924
+35,606
+84% +$3.69M ﹤0.01% 2293
2019
Q4 		$4.52M Buy
+42,318
New +$4.41M ﹤0.01% 3113
2019
Q3 		– Sell
-13,132
Closed -$1.35M – 10272
2019
Q2 		$1.34M Sell
13,132
-17,309
-57% -$1.66M ﹤0.01% 5031
2019
Q1 		$2.74M Buy
+30,441
New +$2.64M ﹤0.01% 3273
2018
Q2 		– Sell
-27,960
Closed -$2.91M – 9715
2018
Q1 		$2.8M Sell
27,960
-56,659
-67% -$5.8M ﹤0.01% 3353
2017
Q4 		$8.33M Buy
84,619
+15,213
+22% +$1.44M ﹤0.01% 1992
2017
Q3 		$6.5M Buy
+69,406
New +$7.37M ﹤0.01% 2197
2017
Q2 		– Sell
-3,769
Closed -$399K – 9287
2017
Q1 		$370K Sell
3,769
-50,721
-93% -$4.84M ﹤0.01% 7023
2016
Q4 		$5.01M Buy
54,490
+35,605
+189% +$3.07M ﹤0.01% 2434
2016
Q3 		$1.6M Sell
18,885
-46,116
-71% -$3.87M ﹤0.01% 3929
2016
Q2 		$5.29M Buy
65,001
+43,248
+199% +$3.29M ﹤0.01% 2126
2016
Q1 		$1.55M Buy
21,753
+9,973
+85% +$669K ﹤0.01% 4240
2015
Q4 		$838K Sell
11,780
-102,529
-90% -$6.89M ﹤0.01% 5773
2015
Q3 		$7.03M Buy
114,309
+15,916
+16% +$1.11M ﹤0.01% 2239
2015
Q2 		$7.13M Buy
98,393
+26,956
+38% +$1.99M ﹤0.01% 2428
2015
Q1 		$5.49M Buy
71,437
+45,271
+173% +$3.24M ﹤0.01% 2612
2014
Q4 		$1.75M Sell
26,166
-14,723
-36% -$929K ﹤0.01% 4708
2014
Q3 		$2.48M Buy
40,889
+35,198
+618% +$2.17M ﹤0.01% 4233
2014
Q2 		$334K Sell
5,691
-132,707
-96% -$7.77M ﹤0.01% 8194
2014
Q1 		$8.02M Buy
138,398
+75,307
+119% +$4.04M ﹤0.01% 2272
2013
Q4 		$3.38M Sell
63,091
-128,781
-67% -$7.64M ﹤0.01% 3491
2013
Q3 		$11.9M Buy
191,872
+32,933
+21% +$1.97M 0.01% 1721
2013
Q2 		$9.64M Buy
+158,939
New +$9.47M 0.01% 1833

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Susquehanna International Group's DGX Position: Q1 2026 in Review

Susquehanna International Group reduced its Quest Diagnostics (DGX) stake by 40% in Q1 2026, selling an estimated $2.35M and leaving 18,519 shares worth $3.63M. The position accounts for ﹤0.01% of the portfolio, ranked #4865.

Susquehanna International Group first reported a position in DGX in Q2 2013 and has held it in 47 quarters since. The position peaked at $11.9M in Q3 2013. 1,066 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Susquehanna International Group held 18,519 shares of Quest Diagnostics worth $3.63M as of Q1 2026.
  • Susquehanna International Group sold 12,109 Quest Diagnostics shares in Q1 2026, an estimated $2.35M.
  • Quest Diagnostics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #4865 holding.
  • Susquehanna International Group first reported a position in Quest Diagnostics in Q2 2013 and has held it in 47 quarters since.
  • Susquehanna International Group's Quest Diagnostics position peaked at $11.9M in Q3 2013.
  • 1,066 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.